Cargando…
Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil
INTRODUCTION: Only 20% of patients with systemic arterial hypertension (SAH) have blood pressure within recommended parameters. SAH has been the main risk factor for morbidity and mortality of cardiovascular diseases, which affects the burden of the Public Health System (PHS). Some studies have show...
Autores principales: | Cazarim, Maurílio de Souza, Pereira, Leonardo Régis Leira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839560/ https://www.ncbi.nlm.nih.gov/pubmed/29509802 http://dx.doi.org/10.1371/journal.pone.0193567 |
Ejemplares similares
-
Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge
por: Cazarim, Maurílio de Souza, et al.
Publicado: (2016) -
Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital
por: Cazarim, Maurilio de Souza, et al.
Publicado: (2020) -
Effect of Medication Therapy Management by Pharmaceutical Care on Blood Pressure and Cardiovascular Risk in Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression
por: de Souza Cazarim, Maurilio, et al.
Publicado: (2023) -
Cost-effectiveness analysis of a pharmacotherapeutic empowerment strategy for patients with type 2 diabetes mellitus
por: Gonçalves, Ana Carolina Oliveira, et al.
Publicado: (2019) -
INSAF-HAS: a tool to select patients with hypertension for pharmaceutical care
por: Girolineto, Beatriz Maria Pereira, et al.
Publicado: (2019)